Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Patient and tumor characteristics (N = 108)

From: Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma

Factors

Values

Age

 Median, years (range)

76 (47–95)

Sex

 Male

77

 Female

31

ECOG PS

 0

85

 1

18

 2

5

Clinical stage

 ΙA

15

 ΙB

64

 ΙΙ

20

 ΙΙΙA

9

Vascular invasion

 Vp0

105

 Vp1

0

 Vp2

2

 Vp3

1

Number of lesions irradiated simultaneously

 1

92

 2

6

 3

7

 4

2

 5

1

History of treatment for the present lesion

 Initial case

72

 Recurrent or residual case

36

Tumor localization

 Central

39

 Peripheral

69

Etiology (overlap present)

 HCV

27

 Alcohol

25

 NASH

23

 HBV

10

 Others

24

 Median follow-up, months (range)

9.7 (2.3–41.1)

 Median tumor diameter, mm (range)

41 (5–160)

Child–Pugh score

 Class A (5 points)

71

 Class A (6 points)

27

 Class B (7 points)

9

 Class B (8 points)

1

ALBI Grade

 Grade 1

60

 Grade 2

48

  1. ECOG PS Eastern Cooperative Oncology Group performance status, Vp portal vein invasion, HCV hepatitis C virus, NASH nonalcoholic steatohepatitis; HBV hepatitis B virus, ALBI albumin–bilirubin